Managing hand dermatitis requires a careful balance between controlling inflammation, protecting the skin’s natural barrier, and avoiding triggers that can worsen symptoms. This common skin condition affects many people, especially those whose work or daily activities expose their hands to water, chemicals, or repeated irritation. While standard treatments have helped many patients find relief, new therapies being tested in clinical trials offer hope for those who struggle with persistent symptoms that don’t respond to traditional approaches.

Understanding Treatment Goals for Troubled Hands

When someone develops hand dermatitis, the main goal of treatment is to calm the inflamed skin, restore the protective outer layer, and prevent future flare-ups. This condition can make everyday tasks painful and difficult, from washing dishes to shaking hands with a colleague. The approach to treatment depends on how severe the symptoms are, what might be causing them, and how the person has responded to previous treatments.^[1]

Treatment isn’t one-size-fits-all. Some people have mild symptoms that respond quickly to simple measures, while others face chronic problems that need stronger medical interventions. Medical societies have established guidelines that help doctors choose the right treatment based on the specific pattern of hand dermatitis and the individual patient’s needs. Beyond the treatments that are already approved and widely used, researchers are actively studying new medications that target the underlying causes of inflammation in different ways.^[4]

The journey to clear skin often requires patience and persistence. For many patients, hand dermatitis comes and goes in cycles, with periods of improvement followed by flare-ups. This chronic nature means that treatment is often a long-term commitment rather than a quick fix. The good news is that with proper management, most people can keep their symptoms under control and maintain the use of their hands for work and daily life.^[8]

Standard Medical Treatments That Doctors Prescribe

The foundation of hand dermatitis treatment starts with protecting and repairing the skin’s natural barrier. This outer layer, called the stratum corneum, acts like a brick wall that keeps moisture in and harmful substances out. When this barrier breaks down, the skin loses water, becomes dry and cracked, and inflammatory cells rush to the area causing redness, swelling, and itching. Simple petroleum-based moisturizers, also called emollients, work remarkably well at restoring hydration and fixing this damaged barrier. These should be applied frequently throughout the day, especially after every hand washing.^[4]

When inflammation needs to be controlled, topical corticosteroids are usually the first medication doctors prescribe. These creams or ointments come in different strengths, from mild to very potent. Because the skin on the hands is relatively thick, doctors often need to prescribe moderate to very strong corticosteroid products. They’re typically applied twice daily, usually right before moisturizing. While very effective at reducing inflammation, these medications need to be used carefully according to directions, as overuse can cause side effects like thinning of the skin.^[7]

For patients who need an alternative to corticosteroids, calcineurin inhibitors like tacrolimus and pimecrolimus offer another way to control inflammation. These non-steroidal creams work by blocking certain parts of the immune system that cause inflammation. They’re particularly useful for people who need long-term treatment or who develop side effects from corticosteroids.^[15]

When topical treatments aren’t enough, doctors may prescribe medications that work throughout the whole body. Short courses of oral corticosteroids like prednisone can provide relief during severe flare-ups. For chronic cases that resist other treatments, immunosuppressant medications such as methotrexate, cyclosporine, or mycophenolate mofetil may be prescribed. These drugs dampen the entire immune system to reduce inflammation, but they require careful monitoring for side effects.^[7]

Another treatment option is phototherapy, which uses ultraviolet light to reduce inflammation in the skin. Patients typically visit a clinic several times a week to have their hands exposed to controlled amounts of UV light. This approach can be helpful for people who haven’t responded to topical treatments, though it requires a significant time commitment.^[11]

In some countries, a medication called alitretinoin (marketed as Toctino) is available for severe chronic hand dermatitis that hasn’t improved with other treatments. This is an oral retinoid, related to vitamin A, that works by affecting how skin cells grow and develop. However, it can cause birth defects, so it’s not suitable for women who might become pregnant.^[11]

If a bacterial infection develops on top of the hand dermatitis, which often shows up as oozing, crusting, or yellow patches, antibiotics become necessary. These can be applied as a cream or taken as pills, depending on the severity of the infection.^[6]

Promising New Therapies in Clinical Research

The landscape of hand dermatitis treatment is changing as researchers develop medications that target specific molecules involved in inflammation. Clinical trials are testing various new approaches that could offer better results with fewer side effects than traditional treatments. These studies progress through different phases, starting with safety testing, then examining whether the drug works, and finally comparing it to existing treatments.^[17]

One of the most exciting developments involves dupilumab, a medication that blocks two important proteins called interleukin-4 and interleukin-13 (IL-4 and IL-13). These proteins play a central role in triggering the inflammatory response that causes eczema symptoms. Dupilumab is given as an injection under the skin, typically every two weeks. It has already been approved for treating atopic dermatitis on other parts of the body, and clinical trials are now studying how well it works specifically for hand dermatitis. Early results have been encouraging, with patients experiencing less itching, reduced inflammation, and improvement in the appearance of their hands.^[17]

Another major class of experimental treatments involves JAK inhibitors, which are medications that block enzymes called Janus kinases. These enzymes act like switches inside cells, turning on the inflammatory signals that lead to eczema symptoms. By blocking these switches, JAK inhibitors can reduce inflammation throughout the skin. Several JAK inhibitors are being tested for hand dermatitis in clinical trials around the world, including in Europe and the United States.^[17]

One such JAK inhibitor is ruxolitinib, which comes as a cream that can be applied directly to the affected skin. In clinical trials, patients using this cream have reported improvements in itching and skin appearance. Because it’s applied topically rather than taken as a pill, it may cause fewer side effects throughout the body.^[17]

Another topical JAK inhibitor in clinical testing is delgocitinib (also known by its code name LEO124249). This ointment has shown promise in early trials for treating hand dermatitis, with participants reporting reduced symptoms and improved quality of life. Researchers are particularly interested in whether this medication can help people whose condition hasn’t responded to conventional treatments.^[17]

Gusacitinib (code name ASN002) is an oral JAK inhibitor being studied in clinical trials. By taking it as a pill, the medication can affect inflammation throughout the body. This might be helpful for people with severe hand dermatitis or those who also have eczema affecting other areas. Studies are examining both the effectiveness of this drug and its safety profile, looking at potential side effects and how well patients tolerate taking it long-term.^[17]

Researchers are also testing a molecule called roflumilast (code name ARQ-252) in cream form. This medication works by blocking an enzyme called phosphodiesterase-4, which is involved in creating inflammatory chemicals in the skin. In clinical trials, patients applying this cream have experienced reductions in redness, scaling, and itching. The advantage of this approach is that it offers yet another way to control inflammation without using corticosteroids.^[17]

Another experimental treatment being investigated is AFX 5931, though details about its exact mechanism of action and trial results are still limited. As with other medications in development, researchers are carefully monitoring both how well it works and what side effects might occur during treatment.^[17]

These new medications represent different strategies for controlling the inflammation that drives hand dermatitis. By targeting specific molecules or pathways, they aim to be more precise than older treatments, potentially offering better results with fewer unwanted effects. The clinical trials testing these drugs typically involve hundreds of patients with hand dermatitis who haven’t improved enough with standard treatments. Participants are closely monitored not only for whether their skin improves, but also for any side effects that might develop.^[17]

One important aspect of these newer treatments is that many show promising safety profiles. In the trials conducted so far, serious side effects have been relatively uncommon, making these medications potentially attractive options for long-term management of hand dermatitis. However, it’s important to remember that these drugs are still being studied, and their full benefit and risk profile won’t be completely understood until the trials are completed and the results are carefully analyzed.^[17]

The fact that there are currently 56 ongoing clinical trials looking at treatments for hand dermatitis, with 16 that are new or currently enrolling patients, shows how much scientific interest there is in finding better ways to help people with this condition. This level of research activity suggests that in the coming years, patients and doctors will have more treatment options to choose from than ever before.^[17]

Most Common Treatment Methods

• Moisturizers and Barrier Protection
  • Frequent application of petroleum-based emollients to restore and maintain skin hydration
  • Use of fragrance-free moisturizers after every hand washing
  • Ointments and creams with higher oil content for better barrier repair
• Topical Corticosteroids
  • Moderate to very potent strength creams or ointments applied twice daily
  • Medications like betamethasone and clobetasol for reducing inflammation
  • Careful use to avoid side effects such as skin thinning
• Topical Calcineurin Inhibitors
  • Non-steroidal alternatives including tacrolimus and pimecrolimus
  • Suitable for long-term use without corticosteroid side effects
• Systemic Immunosuppressants
  • Oral corticosteroids like prednisone for severe flare-ups
  • Longer-term medications including methotrexate, cyclosporine, and mycophenolate mofetil for chronic cases
  • Careful monitoring required due to immune system suppression
• Phototherapy
  • Controlled ultraviolet light exposure several times per week
  • Useful for patients who haven’t responded to topical treatments
• Oral Retinoids
  • Alitretinoin (Toctino) for severe chronic hand dermatitis
  • Not suitable for women who might become pregnant due to birth defect risk
• Antibiotics
  • Topical or oral antibiotics when bacterial infection develops
  • Used for treating oozing, crusting, or pustular symptoms
• Biologic Therapies (in Clinical Trials)
  • Dupilumab targeting IL-4 and IL-13 proteins
  • Injectable medication given every two weeks
  • Showing promising results in early studies for hand dermatitis
• JAK Inhibitors (in Clinical Trials)
  • Topical forms including ruxolitinib and delgocitinib (LEO124249)
  • Oral forms like gusacitinib (ASN002)
  • Block Janus kinase enzymes to reduce inflammatory signals
• PDE-4 Inhibitors (in Clinical Trials)
  • Roflumilast (ARQ-252) cream
  • Blocks phosphodiesterase-4 enzyme involved in inflammation